Jun-Jie Chen is an Assistant Investigator at the Tumor research laboratory, department of medical research, E-da hospital in Kaohsiung, Taiwan. He also served adjunct professor in I-Shou University, school of medicine. He has over 10 year’s research experience in the cancer research. He also leads a research team in the conduct of mission related research program, including the discovery of biomarkers for evaluation of oncology drug products by using pharmacogenomics. His scientific expertise lies in the areas of signal transduction, cell death regulation, cancer therapeutics, drug resistance mechanisms, and cancer biomarkers as evidenced by peer-reviewed articles. Prior to joining E-da hospital, he was a research fellow at division of Therapeutic Proteins, Office of Biotechnology Products, Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA). He earned his Ph.D. in pharmacology from National Taiwan University in 2007. He has received many awards in scientific society including the outstanding award of Wang Ming-Ning foundation in 2006.
Signal transduction; Cell death regulation; Cancer therapeutics; Drug resistance mechanisms; Cancer biomarkers